X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-13 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $10.01 | -3,945 | 175,895 | -2% | -$39,502 | |||||
2023-12-13 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $5.78 | -7,574 | 130,564 | -5% | -$43,764 | ||||||
2023-11-27 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $5.06 | -933 | 138,138 | -1% | -$4,720 | ||||||
2023-05-23 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $12.31 | -982 | 139,071 | -1% | -$12,088 | ||||||
2023-03-14 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $18.73 | -1,293 | 91,717 | -1% | -$24,220 | ||||||
2022-12-16 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $18.98 | -5,371 | 59,254 | -8% | -$101,960 | ||||||
2022-11-23 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $21.57 | -877 | 39,625 | -2% | -$18,918 | ||||||
| D | 2022-10-04 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale+OE | $22.84 | -25,000 | 40,502 | -38% | -$570,980 | |||||
| DM | 2022-09-06 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale+OE | $19.34 | -25,000 | 40,502 | -38% | -$483,540 | |||||
| DM | 2022-08-18 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale+OE | $22.17 | -25,000 | 40,502 | -38% | -$554,347 | |||||
2022-05-24 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $17.10 | -939 | 40,502 | -2% | -$16,058 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |